Furthermore, we provide novel evidence that AnxA1 is not only able to reduce the effects of cerebral I/RI (including reducing the effect of subsequent thrombi forming after cerebral ischemia), but it is able to reduce cerebral thrombosis, a prerequisite for stroke. Here, ANXA1 is linked to brain ischemia.